Thomas, M., Villalobos Bollen, M. A., Reinmuth, N., Penzel, R., & Schnabel, P. A. (2015). Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer. The European respiratory journal, 46(1), . https://doi.org/10.1183/09031936.00229014
Chicago-Zitierstil (17. Ausg.)Thomas, Michael, Matthias Americo Villalobos Bollen, Niels Reinmuth, Roland Penzel, und Philipp Albert Schnabel. "Erlotinib and Bevacizumab Versus Cisplatin, Gemcitabine and Bevacizumab in Unselected Nonsquamous Nonsmall Cell Lung Cancer." The European Respiratory Journal 46, no. 1 (2015). https://doi.org/10.1183/09031936.00229014.
MLA-Zitierstil (9. Ausg.)Thomas, Michael, et al. "Erlotinib and Bevacizumab Versus Cisplatin, Gemcitabine and Bevacizumab in Unselected Nonsquamous Nonsmall Cell Lung Cancer." The European Respiratory Journal, vol. 46, no. 1, 2015, https://doi.org/10.1183/09031936.00229014.